Abu Dhabi now pays day-case procedures on a DRG, and that moves your margin from billing to coding and theatre control.
Since 1 November 2025, Abu Dhabi pays day-case procedures on IR-DRG, not line items. Your margin now rides on coding accuracy and theatre throughput.
What a board member needs before the next meeting on this.
- The line item is dead. The payer sets one price per episode; every consumable is now cost against a fixed price, not a charge you pass through.
- Coding is revenue, not admin. A missed comorbidity drops the case into a lower-weight DRG that pays less for identical clinical work.
- Adjudication regroups, it doesn't trim. A claim the documentation can't support bounces to a lower weight — the whole episode payment is at risk, not one line.
- Margin is theatre control. Two sites bill the same DRG and post different contribution; throughput decides whether the fixed price clears cost.
Since 1 November 2025, day-case surgery in Abu Dhabi is paid the way inpatient care has been for years. The Department of Health extended IR-DRG grouping to ambulatory surgical and medical procedures under the DOH Mandatory Tariff, and the Claims and Adjudication Rules V2025.1 now govern how those encounters are priced and periodically reweighted. If you run a hospital group or a multi-site day-surgery platform, treat this as a margin event, not a billing update.
The line item is dead
Under fee-for-service, a cataract list, an endoscopy suite, or an orthopaedic day unit earned on what you documented. Use an extra consumable, bill an extra consumable. A case-based DRG breaks that reflex. The payer sets one weighted price for the whole episode, derived from the diagnosis and procedure you code. Everything consumed inside that episode is now cost sitting against a fixed price. The implant you used to pass through to the payer is the implant that now decides whether the case clears its margin.
Coding stopped being administration
DRG assignment runs off your ICD-10-CM diagnoses and the procedure codes on the claim, grouped by the international refined DRG system Abu Dhabi has long used for inpatient care. Miss a documented comorbidity, under-state severity, or let a coder default to an unspecified code, and the grouper drops the encounter into a lower-weight DRG that pays less for identical clinical work. The relative weights sit in the Mandatory Tariff and DoH updates that tariff, so a rate you modelled in November can move under you. V2025.1 itself sets no periodic reweighting cadence. A group that still treats coding as back-office data entry is leaving priced revenue on the table at every site, every day.
Adjudication is tighter than the old line-item review
V2025.1 sets the Mandatory Tariff application rules the payer uses to accept, downcode, or reject a claim. A DRG claim that the coded documentation does not support no longer gets trimmed item by item the way it once did. It regroups to a lower weight or it bounces. That raises the cost of a thin clinical note and a weak coding function, because the amount at risk is now the whole episode payment, not one disputed line. Your revenue-cycle team has to read documentation the way the grouper reads it, before the claim leaves the building.
Time and resource discipline is the P&L now
For a day case the stay is measured in hours, but the principle that governs inpatient DRG margin still holds. Theatre minutes, nursing hours per case, recovery-bay turnover, and cancelled-slot rates decide whether the fixed DRG payment clears your cost. Two sites can bill the identical DRG for the identical procedure and post very different contribution, because one turns four cases through a theatre where the other manages three. The tariff is the same for both. The cost base is not.
The exposure is multi-site variation
In a single clinic you can hold coding quality and theatre productivity in one clinician's head. Across a network of centres you cannot. One site codes tightly and runs a lean list; another leaks severity capture and idles theatre time. Under fee-for-service that variance was muted, because volume still billed. Under DRG it compounds straight into consolidated margin, and it stays hidden until you measure coded case-mix index and cost-per-case against the DRG weight, site by site. Malaffi and your Shafafiya submissions already hold the data to do it. Most groups have never turned it into a management report.
Four questions before the next tariff cycle
- What is our coded case-mix index by site, and where is severity capture leaking?
- What does a sample recode against the V2025.1 weights say we are under-billing today?
- What is our cost-per-case by site for the top five day-case DRGs?
- Are theatre schedules built around DRG contribution or around list length?
The work is unglamorous. Recode a sample of recent day cases against the V2025.1 weights, quantify the under-coding leak, benchmark cost-per-case across your sites, and rebuild theatre schedules around DRG contribution rather than list length. Done properly it lifts EBITDA without a single extra patient, because you are recovering revenue you already earned and cost you already control. The groups that move first will reprice their theatre lists and their coding function within the first tariff cycle; the ones that wait will discover the leak only when the year-end numbers come in short. If your group is carrying this exposure across several sites, that is the kind of margin recovery a principal-led conversation with Avior on operational excellence is built to find.